Skip to content Skip to footer
Neuraceq: Benefits, Reviews, Info, Side Effects!
Rx Details
Neuraceq
Florbetaben, Amyvid
Florbetaben F 18
Prescription
Radiotracer
Drugs
Prescription Only
Neuraceq is a radiopharmaceutical used in positron emission tomography (PET) imaging to estimate beta-amyloid neuritic plaque density in the brain, which is associated with Alzheimer’s disease. Here are some benefits of Neuraceq: – Aids in the diagnosis of Alzheimer’s disease, – Helps differentiate Alzheimer’s from other types of dementia, – Provides non-invasive imaging of the brain, – Assists in early detection of Alzheimer’s disease, – Supports clinical decision-making, – Enhances understanding of disease progression, – Facilitates research in Alzheimer’s disease.
Dizziness, Headache, Increased Blood Pressure, Injection Site Pain, Nausea
Neuraceq is a radiopharmaceutical used in positron emission tomography (PET) imaging to estimate beta-amyloid neuritic plaque density in the brain, which is associated with Alzheimer’s disease. The average dosage of Neuraceq is typically 300 megabecquerels (MBq), which is equivalent to about 8.1 millicuries (mCi). However, the exact dosage may vary based on specific clinical protocols and patient factors. It’s important for healthcare providers to follow the manufacturer’s guidelines and adjust the dosage as necessary for individual patients.
Alzheimer’s disease diagnosis
Neuraceq has a generally safe safety profile.
Interactions not reported
$1,500 – $2,000
$1,500

A Synopsis of

Neuraceq

Neuraceq is a medication that is commonly used in the management of Alzheimer’s disease. It is a radioactive diagnostic agent that is administered intravenously to aid in the detection of beta-amyloid plaques in the brain, which are a hallmark characteristic of Alzheimer’s disease.

Neuraceq works by binding to beta-amyloid plaques in the brain, allowing for their visualization through positron emission tomography (PET) imaging. This can help healthcare providers to accurately diagnose Alzheimer’s disease and monitor disease progression over time.

It is important to note that Neuraceq is not a treatment for Alzheimer’s disease, but rather a diagnostic tool that can provide valuable information to healthcare providers and patients. It can help to differentiate Alzheimer’s disease from other forms of dementia and assist in developing an appropriate treatment plan.

As with any medication, Neuraceq may have potential side effects and risks. It is important to discuss these with your healthcare provider before undergoing a Neuraceq scan. Additionally, it is crucial to follow all instructions provided by your healthcare provider to ensure a safe and effective imaging procedure.

Overall, Neuraceq can be a valuable tool in the management of Alzheimer’s disease, providing important information for healthcare providers and patients alike. If you have any questions or concerns about Neuraceq or its use, do not hesitate to speak with your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN